EAGAN, Minn.--(BUSINESS WIRE)--Biothera has expanded the second arm of its clinical trial evaluating whether the combination of Imprime PGG® and Erbitux® can achieve positive outcomes for metastatic colorectal cancer (mCRC) patients without the use of chemotherapy, the company announced today.
